Carbidopa-Levodopa 50mg-200mg CR

Carbidopa-Levodopa 50mg-200mg CR Tablets – Complete Product Description

Carbidopa-Levodopa 50mg-200mg CR (Controlled Release) is a prescription medication used for the treatment and management of Parkinson’s disease and Parkinsonian syndromes. This extended-release formulation contains 50mg of Carbidopa and 200mg of Levodopa, providing sustained delivery of medication to help maintain more stable dopamine levels and improve motor symptom control throughout the day.

Parkinson’s disease is a progressive neurological condition characterized by a reduction in dopamine-producing nerve cells in the brain. As dopamine levels decrease, symptoms such as tremors, muscle rigidity, slow movement, impaired balance, and coordination difficulties can develop. Carbidopa-Levodopa 50mg-200mg CR helps address dopamine deficiency and supports improved movement and daily functioning.

Uses of Carbidopa-Levodopa 50mg-200mg CR

Carbidopa-Levodopa 50mg-200mg CR is commonly prescribed for:

• Parkinson’s disease
• Parkinsonian syndromes
• Long-term dopamine replacement therapy
• Management of motor fluctuations
• Reduction of “wearing-off” effects between doses
• Control of tremors, rigidity, and bradykinesia
• Improvement of mobility and movement coordination

How Carbidopa-Levodopa 50mg-200mg CR Works

Levodopa is converted into dopamine after entering the brain, helping replenish the neurotransmitter that becomes deficient in Parkinson’s disease. Increased dopamine levels help improve communication between nerve cells responsible for movement control.

Carbidopa prevents Levodopa from being broken down before reaching the brain, allowing more medication to become available where it is needed. The controlled-release formulation gradually releases the active ingredients over time, helping provide longer-lasting symptom management and reducing fluctuations in motor performance.

Benefits of Carbidopa-Levodopa 50mg-200mg CR

• Provides extended symptom relief
• Helps maintain consistent dopamine levels
• Reduces motor fluctuations and “off” periods
• Supports smoother and more coordinated movement
• Improves walking ability and balance
• May reduce tremors and muscle stiffness
• Enhances overall quality of life in Parkinson’s patients

Dosage and Administration

Carbidopa-Levodopa 50mg-200mg CR should be used exactly as prescribed by a healthcare professional. Dosage schedules are individualized based on disease severity, treatment response, and previous Parkinson’s therapies.

Controlled-release tablets should be swallowed whole with water. Crushing, chewing, or breaking the tablet may interfere with the controlled-release mechanism and affect how the medication is absorbed.

Patients should take the medication at regular intervals and attend routine medical follow-up appointments to ensure optimal symptom control.

Possible Side Effects

Like all medications, Carbidopa-Levodopa 50mg-200mg CR may cause side effects, although not everyone experiences them.

• Nausea
• Dizziness
• Drowsiness
• Headache
• Dry mouth
• Constipation
• Sleep disturbances
• Low blood pressure when standing
• Involuntary movements (dyskinesia)
• Hallucinations in some patients

Seek immediate medical attention if serious side effects occur, including severe allergic reactions, chest pain, confusion, unusual behavioral changes, or worsening neurological symptoms.

Warnings and Precautions

• Use only under the supervision of a qualified healthcare professional.
• Inform your physician about all medications and supplements you are taking.
• Do not stop treatment abruptly without medical advice.
• Patients with heart disease, glaucoma, liver disorders, or psychiatric conditions should use caution.
• Use caution when driving or operating machinery.
• Regular monitoring may be required during long-term therapy.

Storage Instructions

• Store below 25°C in a cool, dry place.
• Protect from moisture and direct sunlight.
• Keep tablets in their original packaging.
• Keep out of reach of children and pets.
• Do not use after the expiry date printed on the package.

Related Healthcare Resources

Learn more about Parkinson’s disease treatment options and neurological wellness in our
Healthcare Blog.

Need assistance regarding prescriptions, product information, or orders? Visit our
Contact Us Page.

For official safety information and prescribing details, visit

MedlinePlus – Carbidopa and Levodopa Drug Information
.

Frequently Asked Questions (FAQs)

1. What is Carbidopa-Levodopa 50mg-200mg CR used for?

Carbidopa-Levodopa 50mg-200mg CR is used to treat Parkinson’s disease and Parkinsonian syndromes by helping restore dopamine levels and improve movement control.

2. What does CR mean in Carbidopa-Levodopa 50mg-200mg CR?

CR stands for Controlled Release, meaning the medication is released gradually over time to provide longer-lasting symptom control.

3. Can I split or crush Carbidopa-Levodopa 50mg-200mg CR tablets?

No. Controlled-release tablets should generally be swallowed whole because altering them may affect how the medication is released and absorbed.

4. How is the CR version different from immediate-release Carbidopa-Levodopa?

The controlled-release formulation provides a slower, more sustained release of medication, helping reduce fluctuations in symptom control compared to immediate-release tablets.

5. Does Carbidopa-Levodopa 50mg-200mg CR cure Parkinson’s disease?

No. It does not cure Parkinson’s disease but helps manage symptoms, improve mobility, and support a better quality of life.

Medical Disclaimer

This content is intended for informational and educational purposes only and should not be considered medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, changing, or discontinuing any medication. Carbidopa-Levodopa 50mg-200mg CR should be used only under professional medical supervision.